Inhibition of ATP-Sensitive Potassium Channels in Cardiac Myocytes by the Novel Class III Antiarrhythmic Agent MS-551
Donald K. Martin
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorYutaka Nakaya
Second Department of Internal Medicine, Tokushima University, Tokushima, Japan
Search for more papers by this authorKenneth R. Wyse
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorJane A. Bursill
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorPaul D. West
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorTerence J. Campbell
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorDonald K. Martin
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorYutaka Nakaya
Second Department of Internal Medicine, Tokushima University, Tokushima, Japan
Search for more papers by this authorKenneth R. Wyse
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorJane A. Bursill
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorPaul D. West
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorTerence J. Campbell
Departments of Cardiology & Clinical Pharmacology, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney N.S.W. 2010, Australia
Search for more papers by this authorAbstract
Abstract The novel class III antiarrhythmic agent, MS-551, has recently been shown to attenuate the decrease in ventricular effective refractory period and to prevent the subsequent ventricular fibrillation induced by pinacidil and hypoxia in isolated perfused rabbit hearts (Friedrichs et al. 1994). We studied the effects of MS-551 on single ATP-sensitive potassium channels in isolated rabbit ventricular myocytes using standard patch-clamp methods. MS-551 in the range from 1 μM to 100 μM produced a concentration-dependent reduction of the open probability of the ATP-sensitive potassium channel, with an apparent ED50 of 30 μM. This reduced channel activity was due to a smaller number of channel openings per unit time, and the average duration of each opening of the channel was unaffected. This property of MS-551 is likely to be of most significance in ischaemic tissue, where the ATP-sensitive channels are thought to carry the predominant current that shortens the duration of the action potential.
References
- Auchampach, J. A., M. Maruyama, I. Cavero & G. J. Gross: Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation 1992, 86, 311–319.
- Barry, P. H.: JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements. J. Neurosci. Methods. 1994, 51, 107–116.
- Cobbe, S. M.: Modification of class III antiarrhythmic activity in abnormal myocardium. Cardiovasc. Res. 1988, 22, 847–854.
- Colatsky, T. J., C. H. Follmer & C. F. Starmer: Channel specificity in antiarrhythmic drug action. Circulation 1990, 82, 2235–2242.
- Cole, W. C., C. D. McPherson & D. Contag: ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 1991, 69, 571–81.
- Coraboeuf, E.: Ionic basis of electrical activity in cardiac tissues. Amer. J. Physiol. 1978, 234, H101–H116.
- Escande, D., M. Mestre, I. Cavero, J. Brugada & C. Kirchhof: RP58866 and its active enantiomer RP62719 (Terikalent): blockers of the inward rectifer K+ current acting as pure class III antiarrthythmic agents. J. Cardiovasc. Pharmacol. 1992, 20, S106–S113.
- Fan, Z., K. Nakayama & M. Hiraoka: Multiple actions of pinacidil on adenosine triphosphate-sensitive potassium channels in guinea-pig ventricular myocytes. J. Physiol. 1990, 430, 273–295.
- Friedrichs, G. S., L. Chi, S. C. Black, P. J. Manley & B. R. Lucchesi: Antiarrhythmic agent, MS-551, protects against pinacidil+hypoxia-induced ventricular fibrillation in Langendorff-perfused rabbit isolated heart. J. Cardiovasc. Pharmacol. 1994, 23, 120–126.
- Gross, G. J. & J. A. Auchampach: Role of ATP dependent potassium channels in myocardial ischemia. Cardiovasc. Res. 1992, 26, 1011–1016.
-
Hashimoto, K. I. &
J. Kamiya: Cellular electrophysiological effects of MS-551, a new class III antiarrhythmic agent, in various cardiac tissues: comparison with d-sotalol.
Eur. J. Pharmacol.
1990, 183, 1164.
10.1016/0014-2999(90)94252-S Google Scholar
- Haworth, R. A., A. B. Goknur & H. A. Berkoff: Inhibition of ATP-sensitive potassium channels of adult rat heart cells by antiarryhthmic drugs. Circ. Res. 1989, 65, 1157–1160.
- Hondeghem, L. M.: Development of class III antiarrhythmic agents. J. Cardiovasc. Pharmacol. 1992, 20, S17–S22.
- Hondeghem, L. M. & D. J. Snyders: Class III antiarrhythmic agents have a lot of potential but a long way to go - reduced effectiveness and dangers of reverse use-dependence. Circulation 1990, 81, 686–690.
- Kamiya, J., H. Banno, K. Yoshihara & T. Katakami: Antiarrhythmic effect and haemodynamic properties of MS-551, a new class III antiarrhythymic agent, in anaesthetized dogs. Eur. J. Pharmacol. 1990, 183, 1771–1777.
- Kimura, S., A. L. Bassett, H. Wi & R. J. Myerburg: Verapamil diminishes action potential changes during metabolic inhibition by blocking ATP-regulated potassium currents. Circ. Res. 1992, 71, 87–95.
- Martin, D. K., Y. Nakaya, K. R. Wyse & T. J. Campbell: Effects of disopyramide and flecainide on the kinetics of inward rectifier potassium channels in rabbit heart muscle. Brit. J. Pharmacol. 1994, 111, 873–879.
- McManus, O. B., A. L. Blatz & K. L. Magleby: Sampling, log binning, fitting, and plotting durations of open and shut intervals from single channels and the effects of noise. Pflügers Arch. 1987, 410, 530–533.
- Nakaya, H., Y. Takeda, N. Tohse & M. Kanno: Effects of ATP-sensitive K+ blockers on the action potential shortening in hypoxic and ischaemic myocardium. Brit. J. Pharmacol. 1991, 103, 1019–1026.
- Nakaya, H. T., Noritsugu, N., Y. Takeda & M. Kanno: Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Brit. J. Pharmacol. 1993, 109, 157–163.
- Nakayama, K., Z. Fan, F. Marumo & M. Hiraoka: Interrelation between pinacidil and intracellular ATP concentrations on activation of the ATP-sensitive K+ current in guinea pig ventricular myocytes. Circ. Res. 1990, 67, 1124–1133.
- Nichols, C. G., C. Ripoll & W. J. Lederer: ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ. Res. 1991, 68, 280–287.
- Noma, A.: ATP-regulated K+ channels in cardiac muscle. Nature 1983, 305, 147–48.
- Noma, A. & M. Takano: The ATP-sensitive K+ channel. Jap. J. Physiol. 1991, 41, 177–87.
- Shen, W. K., R. T. Tung, M. M. Machulda & Y. Kurachi: Essential role of nucleotide diphosphates in nicorandil-mediated activation of cardiac ATP-sensitive K+ channel. Circ. Res. 1991, 69, 1152–1158.
- Singh, B. N.: Is Class III antiarrhythmic activity important. Cardiovasc. Drugs Ther. 1990, 4, 597–602.
- Trube, G. & J. Hechseler: Potassium channels in isolated patches of cardiac cell membrane. Naunyn-Schmiedeberg's Archiv. Pharmacol. 1983, 322, R64.
- Undrovinas, A. I. N., Burnashev, D. Eroshenko, I. Fleidervish, C. F. Starmer, C. Makielski & L. V. Rosenshtraukh: Quinidine blocks adenosine 5′-triphosphate-sensitive potassium channels in heart. Amer. J. Physiol. 1990, 259, H1069–H1612.
- Veldkamp, M. W., A. C. G. Van Ginneken & L. N. Bouman: Single delayed rectifier channels in the membrane of rabbit ventricular myocytes. Circ. Res. 1993, 72, 865–878.
- Wolleben, C. D., M. C. Sanguinetti & P. K. S. Siegl: Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J. Mol. Cell. Cardiol. 1989, 21, 783–788.
- Wu, B., T. Sato & M. Arita: Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs. Cardiovasc. Res. 1992, 26, 1095–1101.